| Tag | Content |
|---|
EnhancerAtlas ID | HS109-13312 |
Organism | Homo sapiens |
Tissue/cell | Kasumi-1 |
Coordinate | chr2:231321890-231322580 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| RUNX1 | MA0002.2 | chr2:231322246-231322257 | TTCTGTGGTTT | + | 6.32 |
|
| | Number of super-enhancer constituents: 7 | ID | Coordinate | Tissue/cell |
| SE_09384 | chr2:231320724-231324992 | CD14 | | SE_10266 | chr2:231321351-231322930 | CD19_Primary | | SE_10885 | chr2:231272649-231341656 | CD20 | | SE_18487 | chr2:231320965-231325165 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_22757 | chr2:231321449-231322907 | CD8_primiary | | SE_53670 | chr2:231321492-231324812 | Spleen | | SE_62343 | chr2:231275151-231339482 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I230456 | chr2 | 231321647 | 231323115 |
|
Enhancer Sequence | GGCAGGTCTG TGCTGGGGGA AACCTTGAGC CAGAATCTGC AGGGCTCTAC ACCACTGATG 60
CAGGCTTCTT CAGGCACTTC AGTAGGCATG AAGCCCAGTG CTATTGAAGC CAGCTTGCTG 120
CTAGGATGGG CCTCAAGCCC AGTGCCACTT GGTCCAGTTT GGCACTCGGT CTGGTCTGGA 180
TCATGGGTTC ACTGAGGCTG AAATAGTGCT GTAGGAGGCT GAAGACTGAG TTCGCAGGGC 240
TGGCCTGAGT CCTGGGGCTG CAGGATTTAG GTTGGGGTCA GAGTGAGCTT GGAGGTTCAG 300
ACCATGGGTA CTGGCTAGAG TCTGGGGCTT TGGGAGCTGG GTTTTACTGA AGTCGGTTCT 360
GTGGTTTGGG TGTAAGGCAA AGTCTGGTGC TCACTTCCTT CTCCTTTCCC CAAGCATATT 420
GTATCTTGCT CAATGCTGTG CTTCCTGGAG TTGGGGAAGA TGACACAGTG AAACTTTTCT 480
TCCTGCCCTT TTCAATGTGC TCTTTCTTAT TTCTGTGTTT CACTCAGGTG CTGTGATCTT 540
TCATCTGGTT TCCTCAGCTC TTGCAAAGGT ATTTTCATGC ATAGGTCGTT GTTCACATCA 600
GTGTTTCTGC AGGGGATGGA GGGCTGGAGA GTCCTATTCT CCCATCTTGC TCTACTTCTC 660
CCCAATTTTC TAATTATATC TTTATTTTTC 690
|
